
Send us your comments by 10 November 2024

Send us your comments by 30 November 2024

Board elects new vice chair and adopts mid-year report for 2024

Start of safety review of medicines containing finasteride and dutasteride

How to improve quality of marketing authorisation application submissions

Vaccine assessment can support African regulators during ongoing mpox outbreak
Find medicine
What's new
FAQs
Latest news
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.

Public consultation on updated policy to run until 10 November 2024

European medicines agencies network strategy to 2028 – launch of public consultation

Board elects new vice-chair and endorses draft network strategy to 2028 for public consultation

Review of medicines containing finasteride and dutasteride started

Measures to optimise use of the EU's expert resources for faster assessments
Events
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
This is a questions and answers (Q&A) session on the Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API).